FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1

Published:2010-10-19 Issue:21 Volume:70 Page:8651-8661
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Pchejetski Dmitri,Bohler Torsten,Brizuela Leyre,Sauer Lysann,Doumerc Nicolas,Golzio Muriel,Salunkhe Vishal,Teissié Justin,Malavaud Bernard,Waxman Jonathan,Cuvillier Olivier

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

2. Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies;Bioorganic Chemistry;2024-06

3. Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy;International Journal of Biological Macromolecules;2024-06

4. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma;Journal of Oral Pathology & Medicine;2023-11-09

5. Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models;Cancers;2023-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP